PL1965809T3 - Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany - Google Patents

Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany

Info

Publication number
PL1965809T3
PL1965809T3 PL06809743T PL06809743T PL1965809T3 PL 1965809 T3 PL1965809 T3 PL 1965809T3 PL 06809743 T PL06809743 T PL 06809743T PL 06809743 T PL06809743 T PL 06809743T PL 1965809 T3 PL1965809 T3 PL 1965809T3
Authority
PL
Poland
Prior art keywords
fucans
glucans
compositions
intestine
animals
Prior art date
Application number
PL06809743T
Other languages
English (en)
Inventor
John O'doherty
John T O'sullivan
Aditya Julka
Original Assignee
Bioatlantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioatlantis Ltd filed Critical Bioatlantis Ltd
Publication of PL1965809T3 publication Critical patent/PL1965809T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL06809743T 2005-11-21 2006-11-21 Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany PL1965809T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IES20050772 2005-11-21
EP06809743A EP1965809B9 (en) 2005-11-21 2006-11-21 Compositions to improve gut health and animal performance comprising beta-glucans and alfa-fucans
PCT/IE2006/000131 WO2007057873A2 (en) 2005-11-21 2006-11-21 Novel compositions to improve gut health and animal performance and methods of making the same

Publications (1)

Publication Number Publication Date
PL1965809T3 true PL1965809T3 (pl) 2010-02-26

Family

ID=38049053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06809743T PL1965809T3 (pl) 2005-11-21 2006-11-21 Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany

Country Status (9)

Country Link
US (4) US20090148414A1 (pl)
EP (1) EP1965809B9 (pl)
AT (1) ATE442153T1 (pl)
DE (1) DE602006009144D1 (pl)
DK (1) DK1965809T3 (pl)
ES (1) ES2333259T3 (pl)
PL (1) PL1965809T3 (pl)
PT (1) PT1965809E (pl)
WO (1) WO2007057873A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210346443A1 (en) * 2005-11-21 2021-11-11 Bioatlantis Limited Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same
DE602006009144D1 (de) 2005-11-21 2009-10-22 Bioatlantis Ltd Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans
PL2245945T3 (pl) * 2009-04-30 2013-07-31 Tiense Suikerraffinaderij Nv Sposób karmienia tuczników
DK2432478T3 (da) 2009-05-21 2021-12-06 Bioatlantis Ltd Forbedring af gastrointestinal sundhed, immunitet og ydeevne gennem kostintervention
US9463169B2 (en) 2011-08-17 2016-10-11 Microbiome Therapeutics, Llc Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation
US10433549B2 (en) 2013-03-20 2019-10-08 Bioatlantis Limited Non-nematicidal composition and use thereof
ITPD20130133A1 (it) * 2013-05-14 2014-11-15 Sanypet S P A Prodotto per l'alimentazione di cani affetti da disturbi infiammatori dell'intestino
CN104031158B (zh) * 2014-06-10 2016-08-17 浙江宇翔生物科技有限公司 一种从海带中提取硫酸酯多糖的工艺
KR102205829B1 (ko) * 2017-06-14 2021-01-21 기초과학연구원 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체
CN110025639A (zh) * 2019-03-07 2019-07-19 浙江工业大学 酵母葡聚糖组合物在预防便秘中的应用
PT4037666T (pt) 2020-12-08 2024-06-25 Ruminant Biotech Corp Ltd Aperfeiçoamentos de dispositivos e métodos para administração de substâncias a animais
WO2023002252A1 (en) * 2021-07-21 2023-01-26 Bioatlantis Limited Composition comprising beta-glucans and alpha-fucans for improving gut health and animal performance and methods of making the same
EP4492986A1 (en) 2022-03-18 2025-01-22 Fumi Holding B.V. A microbial cell extract, method for obtaining said microbial cell extract and use of said microbial cell extract

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739046A (en) 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
DE3605997A1 (de) 1986-02-25 1987-08-27 Teves Gmbh Alfred Blockiergeschuetzte hydraulische bremsanlage
US4891220A (en) 1988-07-14 1990-01-02 Immudyne, Inc. Method and composition for treating hyperlipidemia
US5811542A (en) 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5622939A (en) 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US6143731A (en) 1989-10-20 2000-11-07 The Collaborative Group, Ltd. Glucan dietary additives
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5576015A (en) 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
AUPN166195A0 (en) 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US6214337B1 (en) 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
US6573250B2 (en) * 1996-06-12 2003-06-03 Takara Shuzo Co., Ltd. Food or beverage additive containing fucoidan and food and beverage containing fucoidan
CA2253573C (en) * 1996-06-12 2005-12-06 Takara Shuzo Co., Ltd. Fucoidan-containing foods or beverages
IT1288713B1 (it) * 1996-12-18 1998-09-23 Crinos Industria Farmaco Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica
US6338856B1 (en) 1998-02-27 2002-01-15 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
US6391331B1 (en) 1998-02-27 2002-05-21 Texas Tech University Direct feeding of seaweed supplement to cattle and swine to enhance carcass quality
US6383538B1 (en) 1998-02-27 2002-05-07 Texas Tech University Producing meat with enhanced shelf-life
US6342242B1 (en) 1998-02-27 2002-01-29 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
DE19962427A1 (de) 1999-12-22 2001-07-12 Nutrinova Gmbh Verkapselte multifunktionelle, biologisch aktive Nahrungsmittelkomponente, Verfahren zu ihrer Herstellung und ihre Anwendung
US6270812B1 (en) 2000-01-31 2001-08-07 Texas Tech University Reducing E. coli content of beef
US6616953B2 (en) 2001-01-02 2003-09-09 Abbott Laboratories Concentrated spent fermentation beer or saccharopolyspora erythraea activated by an enzyme mixture as a nutritional feed supplement
JP2002223727A (ja) * 2001-01-31 2002-08-13 Ribateepu Seiyaku Kk 機能性食品
JP4238726B2 (ja) 2001-06-01 2009-03-18 味の素株式会社 腸疾患用の薬剤
US6939864B1 (en) 2001-07-09 2005-09-06 Purdue Research Foundation Animal feed compositions and methods of using the same
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
KR100436355B1 (ko) * 2001-08-14 2004-06-18 박정호 항산화물질, 옥타코사놀 및 베타글루칸을 함유한 발효음료및 그의 제조방법
JP4169966B2 (ja) * 2001-11-14 2008-10-22 株式会社ヤクルト本社 炎症性腸疾患予防治療剤
US6660722B2 (en) * 2001-11-30 2003-12-09 Laboratoires Goemar S.A. Therapeutical treatments
US6899892B2 (en) 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
US7018986B2 (en) 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
US20050058671A1 (en) 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
JP5448297B2 (ja) 2003-10-16 2014-03-19 テクコム・グループ・リミテッド・ライアビリティ・カンパニー 低減した血中応答を有する低減可消化炭水化物食物
US20050020490A1 (en) 2004-10-18 2005-01-27 Progressive Bioactives Incorporated A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals.
DE202005000192U1 (de) * 2005-01-07 2005-03-24 M C M Klosterfrau Vertriebsgmb Kombinationen aus ß-Glucanen
ATE473636T1 (de) * 2005-02-15 2010-07-15 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
FR2885812B1 (fr) * 2005-05-18 2007-07-27 Goemar Lab Sa Medicament a base de laminarine ou d'oligolaminarines pour le traitement de la septicemie et du choc septique
DE602006009144D1 (de) * 2005-11-21 2009-10-22 Bioatlantis Ltd Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans
DK2432478T3 (da) 2009-05-21 2021-12-06 Bioatlantis Ltd Forbedring af gastrointestinal sundhed, immunitet og ydeevne gennem kostintervention

Also Published As

Publication number Publication date
EP1965809A2 (en) 2008-09-10
PT1965809E (pt) 2009-12-15
WO2007057873A2 (en) 2007-05-24
ES2333259T3 (es) 2010-02-18
US20200368301A1 (en) 2020-11-26
US10688140B2 (en) 2020-06-23
US12485152B2 (en) 2025-12-02
WO2007057873A3 (en) 2007-11-22
DK1965809T3 (da) 2010-01-04
ATE442153T1 (de) 2009-09-15
EP1965809B1 (en) 2009-09-09
EP1965809B9 (en) 2010-07-21
DE602006009144D1 (de) 2009-10-22
US20090148414A1 (en) 2009-06-11
US20180177835A1 (en) 2018-06-28
US10780137B2 (en) 2020-09-22
US20190343905A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
MX2009003305A (es) Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
MX2009006339A (es) Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide.
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
TN2009000398A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds
ATE534383T1 (de) Zusammensetzungen aus n-ä2,4-bis(1,1- dimethylethyl)-5-hydroxyphenylü-1,4-dihydro-4- oxochinolin-3-carboxamid
EA201101164A1 (ru) Иммуногенная композиция
MX2008012400A (es) Azolopirimidinas como inhibidores de actividad de cannabinoide 1.
MX2010005589A (es) Composicion para el cuidado personal.
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
TW200732296A (en) Novel compounds
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
MX2007009356A (es) Compuestos y composiciones como moduladores de ppar.
MX2010001849A (es) Depsipeptidos ciclicos.
PL1965809T3 (pl) Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany
TW200745003A (en) Novel compounds
WO2008073982A3 (en) 5,6-dihydro-1h-pyridin-2-one compounds
JO2578B1 (en) Compounds Theophene benzimidazole